Soc. Generale Call 246.9 Equinor .../ DE000SU9GMZ3 /
14/06/2024 9:46:03 | Diferencia+0.150 | Bid10:39:58 | Ask- | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
4.000EUR | +3.90% | 3.880 Volumen de oferta: 9,000 |
- Tamaño/ Volumen/ Formato de Ask: - |
- | 246.90 NOK | 21/06/2024 | Call |
GlobeNewswire
9:11
Early Signals by WOO X: BTC Faces Downward Trend While TON Ecosystem Reaches New Highs with Surging ...
GlobeNewswire
9:01
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire
9:00
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire
9:00
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire
9:00
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire
8:00
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
GlobeNewswire
7:00
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EH...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página